{"id":489186,"date":"2024-01-18T09:43:07","date_gmt":"2024-01-18T14:43:07","guid":{"rendered":"https:\/\/platohealth.ai\/partner-spotlight-advancing-melanoma-clinical-trials-with-melanoma-research-alliance\/"},"modified":"2024-01-18T10:12:57","modified_gmt":"2024-01-18T15:12:57","slug":"partner-spotlight-advancing-melanoma-clinical-trials-with-melanoma-research-alliance","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/partner-spotlight-advancing-melanoma-clinical-trials-with-melanoma-research-alliance\/","title":{"rendered":"Partner spotlight: Advancing melanoma clinical trials with Melanoma Research Alliance","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"
<\/div>\n

Antidote\u2019s mission is to connect patients with medical research so medical breakthroughs can take place. A key part of our strategy is partnering with nonprofits and patient advocacy groups. We provide our clinical trial matching technology, Antidote Match, at no cost to these organizations, to help patients and caregivers discover new research opportunities and connect  to clinical trials quickly and easily.<\/p>\n

<\/p>\n

Today, we\u2019re spotlighting our partnership with the Melanoma Research Alliance (MRA), the largest nonprofit funder of melanoma research. It is estimated that nearly 100,000 individuals were diagnosed with melanoma in 2023<\/span><\/a>, and it remains the deadliest type of skin cancer. Through MRA\u2019s Clinical Trial Locator powered by Antidote<\/span><\/a>, it is our hope that research studies can engage with patient populations and help advance knowledge of melanoma treatment, prevention, and more.<\/p>\n

The importance of melanoma clinical trials<\/h3>\n

Many patients think of clinical trials as a last resort \u2014 but to advance medical research, it is important to dispel this myth<\/span><\/a>. Jamie Goldfarb, a melanoma survivor, probably said it best in an interview with MRA<\/span><\/a>: \u201c[Clinical trials] aren\u2019t the thing you try on a whim after you\u2019ve tried everything else. They should be considered when you make your first treatment decisions because they are the way to make sure you are getting cutting-edge therapy.\u201d<\/p>\n

What to know about participating in a melanoma clinical trial<\/h3>\n

For those who have not taken part in research, it may be difficult to know what to expect from a clinical trial<\/span><\/a>. Here are a few things to note:<\/p>\n